Parkside Financial Bank & Trust - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$12,556
-20.0%
2730.0%0.00%
-25.0%
Q2 2023$15,690
+97.3%
273
+28.8%
0.00%
+100.0%
Q1 2023$7,951
+50.2%
212
+12.2%
0.00%0.0%
Q4 2022$5,295
+76.5%
189
+61.5%
0.00%
+100.0%
Q3 2022$3,000
-25.0%
1170.0%0.00%0.0%
Q2 2022$4,0000.0%1170.0%0.00%0.0%
Q1 2022$4,000
+33.3%
1170.0%0.00%0.0%
Q4 2021$3,000117
+1362.5%
0.00%
Q2 2021$0
-100.0%
8
-85.2%
0.00%
Q4 2020$1,0000.0%54
+54.3%
0.00%
Q3 2020$1,00035
+59.1%
0.00%
Q2 2020$022
-8.3%
0.00%
Q1 2020$0
-100.0%
24
-38.5%
0.00%
Q3 2019$1,00039
+77.3%
0.00%
Q2 2019$0
-100.0%
22
-26.7%
0.00%
Q1 2019$1,0000.0%30
-25.0%
0.00%
Q4 2018$1,0000.0%400.0%0.00%
Q3 2018$1,00040
+37.9%
0.00%
Q2 2018$0
-100.0%
29
-50.0%
0.00%
Q1 2018$1,0000.0%58
+100.0%
0.00%
Q4 2017$1,0000.0%290.0%0.00%
Q3 2017$1,0000.0%290.0%0.00%
Q2 2017$1,000290.0%0.00%
Q1 2017$029
+26.1%
0.00%
Q4 2016$0230.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders